It is seldom that ASX listed companies come out with a stock that grows ten times in so many years. Although there are best growth stocks in the market, to grow extensively, it needs something more. These stocks were selected by us at the most opportune time with best risk-reward. To know more such stocks having this kind of potential
Pro Medicus Ltd (ASX: PME)
Pro Medicus Ltd (ASX: PME), on 08 May 2025 secured a five-year deal worth A$20 million with University of Iowa Health Care to implement its full Visage 7 cloud-based imaging platform, replacing older systems across the network. April saw a multi-year research partnership established with UCSF, aimed at developing and commercialising healthcare AI solutions using the Visage AI Accelerator. Earlier, in March, the company signed a 7-year A$40 million agreement with LucidHealth, a U.S. radiology service provider, to deploy the Visage 7 Viewer platform across its extensive care network. All 3 deals reflect the growing adoption of Pro Medicus technology within major academic and private health systems across North America.
PME achieved a 31.1% rise in revenue to $97.2 million and a 42.7% increase in net profit to $51.7 million for the 6 months ending December 2024. With no debt and financial assets totalling $182.3 million, Pro Medicus delivered an interim dividend of 25c per share. Revenue from North America reached $86.4 million representing a 34.6% jump, driven by new deals and expanding implementations. The group also maintained strong operating margins of 72% boosted by increased transaction-based earnings.
During this period, PME finalised major contracts with Trinity Health, Duly Health and Lurie Children’s Hospital totaling $365 million across long-term agreements. It also renewed agreements with Mercy Health and an Australian radiology group, adding $130 million in value. Additional Visage modules were purchased by Duke Health and NYU Langone, signalling continued trust in the cloud-based platform and its scalability across multiple clinical environments.
Supply Network Ltd (ASX: SNL)
Supply Network Ltd (ASX: SNL) delivered growth in the first half of FY2025. Revenue reaching $171.2 million, up 17.8% from the prior comparable period. Profit after tax rose by 31.6% to $19.8 million and basic earnings per share increased to 46.2 cents reflecting a 28.3% uplift. The interim dividend of 32.0C per share represented a payout ratio of 69.3%. This strong performance was supported by a ~2.3% gross margin improvement.
Revenue growth was stronger in Australia than in New Zealand, though the difference is narrowing due to focused efforts across both regions. Operating costs rose by 22.5% as the company continued expanding its service capacity and systems. Even though these higher costs, gross profit still outpaced expense growth. Investments targeting transaction efficiency and service quality remain central to operations. Customer demand continues to broaden with much of it coming from independent repairers and private fleets—core focus areas of Supply Network’s alternative parts service model.
Stronger than anticipated sales have accelerated the company’s trajectory, bringing it close to its $350 million revenue target a year ahead of schedule. Planning has already begun for the next growth phase, aiming to support $450 million in revenue by FY2028. Market shifts—such as workshop capacity constraints and evolving vehicle technologies are prompting global manufacturers to collaborate more closely with trusted independent distributors. The Dividend Reinvestment Plan continues to receive strong support allowing the company to balance reinvestment and shareholder returns. The most recent dividend was distributed on 4 April 2025.
(Source: Company Announcements)
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
